Acute myocardial infarction: Clinical characteristics, management and outcome in a Metropolitan Veterans Affairs Medical Center Teaching Hospital

Journal of the American College of Cardiology

Volumn 29, Issue 5, 1997, Pages 915-925

  Mickelson, Judith K ^a   Blum, Cynthia M ^a   Geraci, Jane M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CORONARY ARTERY DILATATION; HEART CATHETERIZATION; HEART INFARCTION; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; RACE DIFFERENCE; REVASCULARIZATION; TREATMENT OUTCOME;

AFRICAN AMERICANS; AGE FACTORS; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; ELECTROCARDIOGRAPHY; HEART CATHETERIZATION; HISPANIC AMERICANS; HOSPITALS, TEACHING; HOSPITALS, VETERANS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; SURVIVAL ANALYSIS; THROMBOLYTIC THERAPY; TREATMENT OUTCOME; UNITED STATES;

EID: 0030997945     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00034-X     Document Type: Article

References (54)

1. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 329:1993;673-682.
2. ISIS-3 a randomized comparison of streptokinase vs tissue-plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction . Lancet. 339:1992;753-770.
3. GISSI-2 a factorial randomized trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction . Lancet. 336:1990;65-71.
4. Guidelines for the early management of patients with acute myocardial infarction. J Am Coll Cardiol. 16:1990;249-292.
5. Grines CL, DeMaria AN. Optimal utilization of thrombolytic therapy for acute myocardial infarction concepts and controversies . J Am Coll Cardiol. 16:1990;223-231.
6. Rogers WJ. Contemporary management of acute myocardial infarction. Am J Med. 99:1995;195-206.
7. Interventions in the treatment of acute myocardial infarction. J Am Coll Cardiol. 25:(Suppl 7):1995;1-51.
8. Emergency Department rapid identification and treatment of patients with acute myocardial infarction . Ann Emerg Med. 23:1994;311-329.
9. Boisjolie CR, Sharkey SW, Cannon CP, et al. Impact of a thrombolysis research trial on time to treatment of acute myocardial infarction in the emergency department. Am J Cardiol. 76:1995;396-398.
10. Maynard C, Weaver WE, Lambrew C, Bowlby LJ, Rogers WJ, Rubinson RM. Factors influencing the time to administration of thrombolytic therapy with recombinant tissue plasminogen activator (data from the National Registry of Myocardial Infarction). Am J Cardiol. 76:1995;548-552.
11. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med. 328:1993;673-679.
12. Simari RD, Berger PB, Bell MR, Gibbons RJ, Holmes DR. Coronary angioplasty in acute myocardial infarction primary, immediate adjunctive, rescue, or deferred adjunctive approach . Mayo Clin Proc. 69:1994;346-358.
13. Rogers WJ, Bowlby LJ, Chandra NC, et al. Treatment of myocardial infarction in the United States (1990-1993). Circulation. 90:1994;2103-2114.
14. Pilote L, Califf RM, Sapp S, et al. Regional variation across the United States in the management of acute myocardial infarction. N Engl J Med. 333:1995;565-572.
15. Gaudagnoli E, Hauptman PJ, Ayanian JZ, Pashos CL, McNeil BJ, Cleary PD. Variation in the use of cardiac procedures after acute myocardial infarction. N Engl J Med. 333:1995;573-578.
16. Rouleau JL, Moye LA, Pfeffer MA, et al. A comparison of management patterns after acute myocardial infarction in Canada and the United States. N Engl J Med. 328:1993;779-784.
17. Pilote L, Racine N, Hlatky MA. Differences in the treatment of myocardial infarction in the United States and Canada a comparison of two university hospitals . Arch Intern Med. 154:1994;1090-1096.
18. Carroll RJ, Horn SD, Soderfeldt B, James BC, Malmberg L. International comparison of waiting times for selected cardiovascular procedures. J Am Coll Cardiol. 25:1995;557-563.
19. Borowsky SJ, Kravitz RL, Laouri M, et al. Effect of physician specialty on use of necessary coronary angiography. J Am Coll Cardiol. 26:1995;1484-1491.
20. Eysmann SB, Douglas PS. Reperfusion and revascularization strategies for coronary artery disease in women. JAMA. 268:1992;1903-1907.
21. Hannan EL, Kilburn H, O'Donnell JF, Lukacik G, Shields EP. Interracial access to selected cardiac procedures for patients hospitalized with coronary artery disease in New York State. Med Care. 29:1991;430-441.
22. Maynard C, Fisher LD, Passamani ER, Pullum T. Blacks in the Coronary Artery Surgery Study (CASS) race and clinical decision making . Am J Public Health. 76:1986;1446-1448.
23. Ford E, Cooper R, Castaner A, Simmons B, Mar M. Coronary arteriography and coronary bypass survey among whites and other racial groups relative to hospital-based incidence rates for coronary artery disease findings from the NHDS . Am J Public Health. 79:1989;437-440.
24. Wenneker M, Epstein AM. Racial inequalities in the use of procedures for patients with ischemic heart disease in Massachusetts. JAMA. 261:1989;253-257.
25. Goldberg KC, Hartz AJ, Jacobsen SJ, Krakauer H, Rimm AA. Racial and community factors influencing coronary bypass graft surgery rates for all 1986 Medicare patients. JAMA. 267:1992;1473-1477.
26. Whittle J, Conigliaro J, Good CB, Lofgren RP. Racial differences in the use of invasive cardiovascular procedures in the department of Veterans Affairs medical system. JAMA. 329:1993;621-627.
27. Jollis JG, Ancukiewicz M, DeLong ER, Pryor DB, Muhlbaier LH, Mark DB. Discordance of databases designed for claims payment versus clinical informations systems. Ann Intern Med. 119:1993;844-859.
28. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data Differing perspectives . J Clin Epidemiol. 46:1993;1075-1079.
29. Melfi C, Holleman E, Arthur D, Katz B. Selecting a patient characteristics index for the prediction of medical outcomes using administrative claims data. J Clin Epidemiol. 48:1995;917-926.
30. Hosmer JA, Lemeshow S. Applied Logistic Regression. 1989;John Wiley & Sons, New York.
31. Every NR, Fihn SD, Maynard C, Martin JS, Weaver WD. Resource utilization in treatment of acute myocardial infarction staff-model health maintenance organization versus fee-for-service hospitals . J Am Coll Cardiol. 26:1995;401-406.
32. Mark DB, Naylor CD, Hlatky MA, et al. Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. N Engl J Med. 331:1994;1130-1135.
33. Aguirre FV, Younis LT, Chaitman BR, et al. Early and 1-year clinical outcome of patients evolving non-Q-wave versus Q-wave myocardial infarction after thrombolysis. Circulation. 91:1995;2541-2548.
34. Yedidia MJ. The impact of social factors on the content of care treatment of ischemic heart disease at a public and a voluntary hospital . Arch Intern Med. 152:1992;595-600.
35. Peterson ED, Wright SM, Daley J, Thibault GE. Racial variation in cardiac procedure use and survival following acute myocardial infarction in the Department of Veterans Affairs. JAMA. 271:1994;1175-1180.
36. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med. 320:1989;618-627.
37. Liao Y, Cooper RS, Ghali JK, Szocka A. Survival rates with coronary artery disease for black women compared with black men. JAMA. 268:1992;1867-1871.
38. Maynard C, Fisher LD, Passamani ER. Survival of black persons compared with white persons in the Coronary Artery Surgery Study (CASS). Am J Cardiol. 60:1987;513-518.
39. Simmons B, Castaner A, Santhanam V, et al. Outcome of coronary artery bypass grafting in black persons. Am J Cardiol. 59:1987;547-551.
40. Maynard C, Fisher LD, Passamani ER, Pullum T. Blacks in the Coronary Artery Surgery Study risk factors and coronary artery disease . Circulation. 74:1986;64-71.
41. Taylor HA, Chaitman BR, Rogers WJ, et al. Race and prognosis after myocardial infarction results of the Thrombolysis in Myocardial Infarction (TIMI) phase II trial . Circulation. 88:1993;1484-1494.
42. Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction ISIS-2 . Lancet. 2:1988;349-360.
43. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1:1986;397-402.
44. Weaver WD, Cerqueira MD, Hallstrom AP, et al. Prehospital-initiated vs hospital-initiated thrombolytic therapy. JAMA. 270:1993;1211-1216.
45. Cannon CP, Antman EM, Walls R, Braunwald E. Time as an adjunctive agent to thrombolytic therapy. J Thromb Thrombolysis. 1:1994;27-34.
46. Moses HW, Bartolozzi JJ, Koester DL, et al. Reducing delay in the emergency room in administration of thrombolytic therapy for myocardial infarction associated with ST elevation. Am J Cardiol. 68:1991;251-253.
47. Gonzalez ER, Jones LA, Ornato JP, Bleecker GC, Strauss MJ. Hospital delays and problems with thrombolytic administration in patients receiving thrombolytic therapy: a multicenter prospective assessment. Ann Emerg Med. 21:1992;1215-1221.
48. Pell ACH, Miller HC, Robertson CE, Fox KAA. Effects of 'fast track' admission for acute myocardial infarction on delay to thrombolysis. BMJ. 304:1992;83-87.
49. Muller JE, Stone PH, Turi ZG, et al. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med. 313:1985;1315-1322.
50. Tofler GH, Brezinski D, Schafer AI, et al. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med. 316:1987;1514-1518.
51. Matetzky S, Barabash GI, Rabinowitz B, et al. Q wave and non-Q wave myocardial infarction after thrombolysis. J Am Coll Cardiol. 26:1995;1445-1451.
52. Chung MK, Bosner MS, McKenzie JP, Shen J, Rich MW. Prognosis of patients ≥70 years of age with non-Q wave acute myocardial infarction compared with younger patients with similar infarcts and with patients ≥70 years of age with Q wave acute myocardial infarction. Am J Cardiol. 75:1995;18-22.
53. Kennedy HL, Rosenson RS. Physician use of beta-adrenergic blocking therapy a changing perspective . J Am Coll Cardiol. 26:1995;547-552.
54. Naylor CD, Levinton CM, Baigrie RS. Adapting to waiting lists for coronary revascularization. Chest. 101:1992;715-722.